SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-17-004668
Filing Date
2017-05-03
Accepted
2017-05-02 20:37:41
Documents
4
Effectiveness Date
2017-05-03

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 46269
2 image_001.jpg GRAPHIC 10695
3 image_002.jpg GRAPHIC 6468
4 image_003.jpg GRAPHIC 10208
  Complete submission text file 0001493152-17-004668.txt   85338
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37648 | Film No.: 17806907
SIC: 2835 In Vitro & In Vivo Diagnostic Substances